- BrandMars Therapeutics & Chimicals Ltd
- Country of manufactureIndia
Producer: Mars Therapeutics & Chimicals Ltd. India
GENERAL INFORMATION
Enrofloksatsin solution for oral application — the antibacterial medicine intended for treatment of bacterial and mikoplazmenny infections of young growth of farm animals and a bird.
Enrofloksatsin the 100th solution for oral application in 1 sm3v quality of active ingredient contains 100 mg of an enrofloksatsin, and also auxiliary components — sodium bisulphite, potassium hydroxide, etilendiamintetrauksusny acid, water for injections.
Medicine on appearance represents transparent liquid of light yellow color.
PHARMACOLOGICAL PROPERTIES
Enrofloksatsin who is a part of a preparation treats group of ftorkhinolon, possesses a wide range of antibacterial and antimikoplazmenny action, suppresses growth and development of grampolozhitelny and gramotritsatelny bacteria, including Escherichia coli, Haemophilias, Pasteurella, Salmonella, Staphylococcus, Streptococcus, Clostridium, Bordetella, Compylobacter, Corinebacterium, Pseudomonas, Proteus, and also Mycoplasma spp.
The mechanism of action of an enrofloksatsin consists in inhibition of activity of the enzyme of a giraza influencing replication of a spiral of DNA in a kernel of a bacterial cage.
At oral introduction enroflkosatsin it is quickly soaked up in a digestive tract and gets into all bodies and body tissues. enrofloksatsin reaches the maximum concentration in blood in 1-2 hours, therapeutic concentration remains within 24 hours. It is removed enrofloksatsin generally in not changed look and partially in the form of a metabolite — ciprofloxacin, mainly with urine and bile.